Effect of Preoperative Rectus Sheath Block on Quality of Recovery in Single Port Laparoscopic Adnexal Surgery

Sponsor
Yonsei University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05984212
Collaborator
(none)
56
1
2
11
5.1

Study Details

Study Description

Brief Summary

In this study, the investigators aimed to demonstrate if the quality of recovery in patients undergoing single-port laparoscopic adnexal surgery, with preoperative rectus sheath block and intraoperative opioid administration based on analgesia nociception index, improves compared to the patients without block.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ultrasound guided rectus sheath block with dexmedetomidine
  • Drug: Ultrasound guided rectus sheath block with normal saline
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Double blind randomized controlled trialDouble blind randomized controlled trial
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Investigator prepared the drug and participant and outcomes assessor were blind to the group allocation
Primary Purpose:
Supportive Care
Official Title:
Effect of Preoperative Rectus Sheath Block on Quality of Recovery in Single Port Laparoscopic Adnexal Surgery: A Randomized Controlled Trial
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: dexmedetomidine infusion group

Drug: Ultrasound guided rectus sheath block with dexmedetomidine
Intervention Group: Ultrasound guided rectus sheath block with 0.5% ropivacaine 20ml at each side (bilateral)

Placebo Comparator: normal saline infusion group

Drug: Ultrasound guided rectus sheath block with normal saline
Control Group: Ultrasound guided rectus sheath block with 0.9% normal saline 20ml at each side (bilateral)

Outcome Measures

Primary Outcome Measures

  1. Quality of Recovery 40 scale score at postoperative 24 hour [24 hours after the end of surgery]

    Postoperative quality of recovery according to the block performance

Secondary Outcome Measures

  1. Intraoperative remifentanil consumption,postoperative pain score [at 0, 1, 6, 12, and 24 hours postoperative]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  2. rescue analgesics administered up to 24 hours postoperatively [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  3. satisfaction with pain control [intraoprative and postoperative 24hours]

    Patient self-rated overall satisfaction with pain control. Evaluated on an 11-point scale from 0 to 10, with 0 points for completely dissatisfied and 10 points for complete satisfaction. The higher the number, the more satisfactory it is.

  4. serum cortisol level (μg/dL) before and after surgery [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  5. leukocyte level (10^3/μL) before and after surgery [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  6. arterial pH before and after surgery [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  7. blood glucose level (mg/dL) before and after surgery [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

  8. measurement of adequate analgesia (NRS <4) before and after surgery [intraoprative and postoperative 24hours]

    To evaluate the effect of rectus sheath block on intraoperative and postoperative pain and patients' satisfaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adult female patient aged 19 years or older undergoing elective single-port laparoscopic adnexal surgery under general anesthesia at Yonsei Cancer Center

  2. patients with moderate to severe pain before surgery 2. patients with history of taking chronic analgesic use, 3. patients allergic or hypersensite to remifentanil or local anesthetic (ropivacaine), 4. patients with infection at the site of the block, 5. patietns who cannot communicate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Severance hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Yonsei University

Investigators

  • Principal Investigator: Youngwon Kim, Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT05984212
Other Study ID Numbers:
  • 4-2023-0611
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023